Anyone who has questions re anything Immutep should contact Catherine Strong at investor relations. She’s great.
Here is a copy of a reply about a query I had on IMP761 progress( received today)…
”Apologies, I didn’t manage to come back to you earlier. It is very nice to be contacted by a supportive excited shareholder.
IMP761 is an important and promising candidate in the IMM portfolio of four LAG-3 therapies. While we haven’t lodged many recent updates about it via the ASX, preparatory work has been going on behind the scenes to advance it towards the clinic. Immutep has been continuing its GMP manufacturing preparations for IMP761 in recent months and is planning for toxicology studies and other pre-clinical evaluations of the candidate.
There haven’t been any particular hurdles, but the company is always mindful it is operating with limited resources and has to prioritise accordingly.”
Anyone who has questions re anything Immutep should contact...
-
- There are more pages in this discussion • 376 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
-0.040(11.9%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 33.0¢ | 28.0¢ | $7.278M | 23.75M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 53192 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 41048 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |